Star Seyedkazemi, Pharm.D.
Dr. Star Seyedkazemi joined Pliant Therapeutics as Vice President Portfolio Management in October 2020 with responsibility for developing, implementing and overseeing strategic portfolio management and ensuring the successful end-to-end delivery of projects and programs for Pliant and our collaborators. Before joining Pliant, Dr. Seyedkazemi served as Associate Vice President at AbbVie, where she was responsible for clinical and global program leadership for the development of cenicriviroc for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. She has more than fifteen years of pharmaceutical industry experience in global drug development program leadership, clinical research and development, and medical affairs across multiple therapeutics areas, including fibrosis, NASH, HCV and HIV at AbbVie, Allergan, Tobira Therapeutics, Gilead Sciences, Johnson & Johnson and Abbot Laboratories, preceded by 7 years in HIV clinical care and research. Dr. Seyedkazemi earned her Doctor of Pharmacy degree at Nova Southeastern University (NSU) and completed a HIV/Infectious Disease residency at NSU and Broward Health in Fort Lauderdale, FL.